Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma

被引：0
|
作者：
Ciesielski, Michael J.
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Peereboom, David M.
Figel, Sheila A.
Hutson, Alan
Groman, Adrienne
Withers, Henry G.
Liu, Song
Belal, Ahmed
Qiu, Jing-Xin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle M.
Mechtler, Laszlo
Fenstermaker, Robert Alan
机构：
[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[2] Taussig Canc Inst, Neurol Inst, Rose Ella Burkhardt Brain Tumor & Neuro Oncol Ctr, Cleveland, OH USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Beth Israel Deaconess Med Ctr, Boston, MA USA
[8] MimiVax, Buffalo, NY USA
[9] Dent Neurol Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2037
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Single Arm Prospective Trial on BOLD fMRI Radiation-Induced Changes in Newly Diagnosed Glioblastoma Patients
    Buss, E. J.
    Wu, P. B.
    Yanagihara, T.
    Grinband, J.
    Wang, T. J. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S16 - S17
  • [32] Orismilast for the treatment of moderate to severe Ulcerative Colitis: Analysis of preliminary data from UCORIS, a phase 2a, open-label, single-arm exploratory clinical trial
    Honore, T. Velte
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    Copenhagen IBD Ctr
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1766 - i1766
  • [33] FINAL RESULTS OF THE MGMT UNMETHYLATED ARM OF PARADIGM-2: A PHASE I STUDY OF OLAPARIB AND RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Derby, S. J.
    Sweeting, L.
    Shad, S.
    Paterson, L.
    Stobo, J.
    Nowicki, S.
    Williamson, A.
    James, A.
    Short, S. C.
    McBain, C.
    Herbert, C.
    Powell, J.
    Kelly, C.
    Chalmers, A. J.
    NEURO-ONCOLOGY, 2023, 25
  • [34] A phase II, multicenter, single-arm trial of eribulin in patients with bevacizumab-resistant recurrent glioblastoma
    Takahashi, Masamichi
    Kawashima, Satoshi
    Otake, Yohei
    Satomi-Tsushita, Natsuko
    Kuchiba, Aya
    Sadachi, Ryo
    Ohata, Keiko
    Ozawa, Hitoshi
    Yonemori, Kan
    Nagane, Motoo
    Arakawa, Yoshiki
    Mukasa, Akitake
    Tanaka, Shota
    Nishikawa, Ryo
    Muragaki, Yoshihiro
    Masutomi, Kenkichi
    Ichimura, Koichi
    Nakamura, Kenichi
    Narita, Yoshitaka
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] A PHASE 0/2 'TRIGGER' TRIAL OF NIRAPARIB IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Zhang, Hualin
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Braun, Kelly
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2023, 25
  • [36] Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial
    Campbell, Matthew
    Balderrama-Brondani, Vania
    Jimenez, Camilo
    Tamsen, Gina
    Marcal, Leonardo P.
    Varghese, Jeena
    Shah, Amishi Y.
    Long, James P.
    Zhang, Miao
    Ochieng, Joshua
    Haymaker, Cara
    Habra, Mouhammed Amir
    LANCET ONCOLOGY, 2024, 25 (05): : 649 - 657
  • [37] Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
    Eugene Shenderov
    Angelo M. De Marzo
    Tamara L. Lotan
    Hao Wang
    Sin Chan
    Su Jin Lim
    Hongkai Ji
    Mohamad E. Allaf
    Carolyn Chapman
    Paul A. Moore
    Francine Chen
    Kristina Sorg
    Andrew M. White
    Sarah E. Church
    Briana Hudson
    Paul A. Fields
    Shaohui Hu
    Samuel R. Denmeade
    Kenneth J. Pienta
    Christian P. Pavlovich
    Ashley E. Ross
    Charles G. Drake
    Drew M. Pardoll
    Emmanuel S. Antonarakis
    Nature Medicine, 2023, 29 : 888 - 897
  • [38] Neoadjuvant enoblituzumab in localized prostate cancer: a single-arm, phase 2 trial
    Shenderov, Eugene
    De Marzo, Angelo M. M.
    Lotan, Tamara L. L.
    Wang, Hao
    Chan, Sin
    Lim, Su Jin
    Ji, Hongkai
    Allaf, Mohamad E. E.
    Chapman, Carolyn
    Moore, Paul A. A.
    Chen, Francine
    Sorg, Kristina
    White, Andrew M. M.
    Church, Sarah E. E.
    Hudson, Briana
    Fields, Paul A. A.
    Hu, Shaohui
    Denmeade, Samuel R. R.
    Pienta, Kenneth J. J.
    Pavlovich, Christian P. P.
    Ross, Ashley E. E.
    Drake, Charles G. G.
    Pardoll, Drew M. M.
    Antonarakis, Emmanuel S. S.
    NATURE MEDICINE, 2023, 29 (4) : 888 - 897
  • [39] Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial
    Huang, Rui
    Lin, Xiaonan
    Zhang, Yuming
    Su, YongZhong
    Wang, Caixia
    Zhou, Jihao
    Huang, Zhenqian
    Huang, Jinxiong
    Zhang, Xiong
    Zhao, Ying
    Liang, Yuexiong
    Wang, Xiaotao
    Gu, Xuekui
    He, Honghua
    Zheng, Yaling
    Tu, Sanfang
    Chen, FeiHeng
    Lin, Shaoze
    Wang, Yaya
    Dong, Ying
    Huang, Pengcheng
    Liu, Zenghui
    Xu, Xiaoli
    Liang, Zhao
    Zhou, Xuan
    Li, Meifang
    Luo, Man
    Wu, Ming
    Jiang, Fang
    Liu, Qin
    Zeng, Hui
    Song, Chaoyang
    Li, Yuhua
    BLOOD, 2023, 142
  • [40] IORT for Brain Metastases: Final First-Stage Results of a Single-Arm, Open-Label, Phase 2 Trial
    Castro, D.
    Sanematsu, P., Jr.
    Pellizzon, A. C.
    Suzuki, S.
    Fogaroli, R.
    Dias, J. E., Jr.
    Gondim, G.
    Estrada, D.
    Silva, M. L.
    Rassi, M.
    Chen, M.
    Giacomelli, R.
    Ramos, H.
    Neto, E.
    Abrahao, C.
    Coelho, T.
    Yu, L.
    Tannous, C.
    Calsavara, V.
    Giordano, F.
    Oliveira, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S971 - S972
12345